Gene and Cell Therapy
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Advances in Non-Viral Vectors for Gene Therapy and Gene Delivery (Deadline: 28 February 2026)
- New Strategies in Gene and Cell Therapy for Neurological Disorders (Deadline: 20 March 2026)
- Extracellular Matrix and Vesicles as Immunomodulatory Therapeutics (Deadline: 30 March 2026)
- Oligonucleotide Aptamers for Diagnostics and Therapy (Deadline: 31 March 2026)
- Impact of Lipid Nanoparticle Physicochemical Properties on mRNA Vaccine (Deadline: 30 April 2026)
- Design, Development and Biomedical Applications of Hyaluronic Acid-Based Drug and Gene Delivery Systems (Deadline: 30 April 2026)
- Innovative Therapies for Neurodegenerative Diseases (Deadline: 10 May 2026)
- Development and Drug Delivery in Epigenetic Therapy (Deadline: 31 May 2026)
- Next-Generation Non-Viral Vectors for Gene Therapy and DNA Vaccination (Deadline: 20 June 2026)
- Adeno-Associated Virus (AAV) as a Vector for Gene Therapy (Deadline: 30 June 2026)
- Extracellular Vesicle-Based Delivery System for Cancer and Neurodegenerative Disease Treatment (Deadline: 15 July 2026)
- Translating Gene Therapies from Bench to Bedside (Deadline: 20 August 2026)
- Smart Drug Delivery Systems for Immunotherapeutic Agents (Deadline: 20 August 2026)
- mRNA Therapy for Cardiovascular Diseases (Deadline: 31 August 2026)
- Development of Oncolytic Viruses as Platforms for Drug Delivery to Cancers (Deadline: 31 August 2026)
- Next-Generation for mRNA Vaccine Delivery (Deadline: 20 September 2026)
- Polymer-Based Nanotechnology Delivery Systems for Nucleic Acids (Deadline: 30 September 2026)
- Functional Polymers for Targeted Therapeutics and Gene Delivery (Deadline: 30 September 2026)
- From Bench to Bedside: AAV, Lentivirus, Adenovirus, and Retrovirus in Gene Therapy (Deadline: 31 October 2026)
- Gene- and Peptide-Based Therapeutics for Neurodegenerative Disorders (Deadline: 31 December 2026)
- Nanoparticle-Based Gene Delivery (Deadline: 31 December 2026)
